I'm guessing but every biotech CEO must have intestinal fortitude just to put a drug through a trial. He sounded strong to me judging by his opening remarks. This board is irrelevant to him and Rosen are bed bugs which can be dealt with.
I think he sleeps just fine. Remember he is in the "know". He knows exactly how valuable this company is worth...and he gives us hints over and over and over, but apparently the market doesn't hear. They will in the end, when a value can be proved and at that point it will be far too late to buy shares at 1.08. Lol
Prurisol and B-OM may be keeping him awake a bit since they are blinded, but B and K seem on track. There's some trial results early this year that will buoy the share price, at least for a while :-)